Mustang Bio, Inc.
MBIO
$1.11
$0.021.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 88.95% | 85.98% | 49.50% | 68.90% | 56.12% |
| Total Depreciation and Amortization | -79.34% | -86.10% | -99.84% | -18.88% | -56.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | 90.09% | 105.93% | -27.17% | -67.66% | -42.35% |
| Change in Net Operating Assets | -3,079.21% | 58.64% | 548.20% | 61.63% | -106.91% |
| Cash from Operations | 72.47% | 85.39% | 81.16% | 70.12% | 52.55% |
| Capital Expenditure | -- | -- | -- | -- | 68.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | -- | -- | -- | -- | 92.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 26.47% | 359.68% | 6,656.82% | -- | 439,700.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -41.63% | -4,866.67% | -- | -- | -- |
| Cash from Financing | 24.77% | 305.60% | 117.39% | -- | 395,500.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 188.31% | 87.24% | 106.86% | 70.40% | 78.81% |